Valuation: Elekta AB (publ)

Market Cap 19.64B 2.03B 1.78B 1.65B 1.52B 2.87B 194B 2.92B 7.7B 95.34B 7.62B 7.45B 329B P/E 2027 *
13.8x
P/E 2028 * 12.3x
Enterprise Value 23.12B 2.39B 2.09B 1.94B 1.79B 3.38B 229B 3.44B 9.07B 112B 8.97B 8.77B 388B EV / Sales 2027 *
1.33x
EV / Sales 2028 * 1.25x
Free-Float
94.03%
Yield 2027 *
4.87%
Yield 2028 * 5.37%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 2025-08-31
Director of Finance/CFO - 2026-02-28
Investor Relations Contact - 2023-11-30
Director TitleAgeSince
Director/Board Member 69 2010-06-29
Director/Board Member 70 2011-09-14
Chairman 74 2013-09-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 2.04B
+1.14%+2.80%+25.09%+1.03% 196B
+0.91%-5.05%-20.42%+18.45% 144B
+0.55%+3.15%+1.00%-16.37% 141B
+0.01%+0.44%-57.06%-15.14% 66.54B
-0.09%-3.06%+17.87%-0.88% 53.09B
+2.80%+1.95%-22.68%-30.55% 44.12B
-0.30%+2.36%+11.33%+12.01% 37.93B
-0.76%-1.59%+22.58%+38.48% 36.96B
+1.42%+1.40%-11.69%-19.23% 29.43B
Average +0.65%-0.75%-3.78%-1.36% 83.21B
Weighted average by Cap. +0.72%-0.83%-1.09%-0.72%

Financials

2027 *2028 *
Net sales 17.35B 1.79B 1.57B 1.46B 1.34B 2.53B 171B 2.58B 6.8B 84.21B 6.73B 6.58B 291B 18.1B 1.87B 1.64B 1.52B 1.4B 2.64B 179B 2.69B 7.1B 87.88B 7.02B 6.87B 304B
Net income 1.43B 147M 129M 120M 110M 208M 14.1B 212M 559M 6.92B 553M 541M 23.91B 1.61B 166M 145M 135M 124M 234M 15.87B 239M 630M 7.79B 623M 609M 26.92B
Net Debt 3.48B 360M 316M 292M 269M 509M 34.43B 519M 1.37B 16.91B 1.35B 1.32B 58.4B 3B 310M 272M 252M 232M 439M 29.7B 447M 1.18B 14.59B 1.17B 1.14B 50.38B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-